S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
Lowest-Rated Stocks  
NYSE:ZBH

Zimmer Biomet - ZBH Stock Forecast, Price & News

$124.40
-1.44 (-1.14%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$124.34
▼
$126.32
50-Day Range
$104.85
▼
$125.84
52-Week Range
$100.39
▼
$135.05
Volume
1.45 million shs
Average Volume
1.40 million shs
Market Capitalization
$26.11 billion
P/E Ratio
94.24
Dividend Yield
0.76%
Price Target
$124.05

Zimmer Biomet MarketRank™ Forecast

Analyst Rating
Hold
2.05 Rating Score
Upside/​Downside
0.3% Downside
$124.05 Price Target
Short Interest
Healthy
1.08% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
1.46%
From $6.84 to $6.94 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

Medical Sector

171st out of 1,034 stocks

Surgical Appliances & Supplies Industry

9th out of 23 stocks

See Top Rated MarketRank™ Stocks Here
ZBH stock logo

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

December 8, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) Procedure Volume Gain Aids Amid FX Hurdles
November 30, 2022 | seekingalpha.com
Zimmer Biomet: Procedural Volumes Normalizing, Rate Buy
November 21, 2022 | finance.yahoo.com
Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement
November 21, 2022 | finance.yahoo.com
Zimmer Biomet to Present at the 34th Annual Piper Sandler Healthcare Conference
November 10, 2022 | finance.yahoo.com
ZimVie Inc. (ZIMV) Q3 2022 Earnings Call Transcript
November 8, 2022 | finance.yahoo.com
Zimmer Biomet Holdings Third Quarter 2022 Earnings: Beats Expectations
November 5, 2022 | markets.businessinsider.com
Zimmer Biomet Reports Positive Data From Mymobility Clinical Study
November 4, 2022 | markets.businessinsider.com
Robert W. Baird Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
November 4, 2022 | finance.yahoo.com
Is Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Recent Price Movement Underpinned By Its Weak Fundamentals?
November 3, 2022 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Zimmer Biomet Holdings (ZBH)
November 2, 2022 | seekingalpha.com
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Call Transcript
November 2, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) Surpasses Q3 Earnings and Revenue Estimates
November 2, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) Q3 Earnings Beat, Gross Margin Falls
November 2, 2022 | markets.businessinsider.com
Zimmer Biomet Holdings Inc. Q3 Income Advances
October 20, 2022 | msn.com
Patients are getting surgeries again, says J&J
October 20, 2022 | nasdaq.com
Zimmer Biomet Holdings, Inc. Common Stock (ZBH)
October 17, 2022 | finance.yahoo.com
Is There An Opportunity With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) 35% Undervaluation?
October 15, 2022 | seekingalpha.com
ZBH Zimmer Biomet Holdings, Inc.
October 7, 2022 | nasdaq.com
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) P/E Still Appears To Be Reasonable
October 5, 2022 | finance.yahoo.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2022 Financial Results
September 21, 2022 | finance.yahoo.com
Zimmer Biomet (ZBH) to Offer New Shoulder Replacement System
September 20, 2022 | markets.businessinsider.com
Zimmer Biomet Receives FDA 510(k) Clearance For Identity Shoulder System
September 20, 2022 | finance.yahoo.com
Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement
September 13, 2022 | finance.yahoo.com
Zimmer (ZBH) Surges 4.2%: Is This an Indication of Further Gains?
September 12, 2022 | nasdaq.com
ZBH Crosses Above Key Moving Average Level
See More Headlines
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 10/31 Dividend
9/29/2022
Dividend Payable
10/31/2022
Last Earnings
11/02/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/06/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:ZBH
Previous Symbol
NYSE:ZMH
CUSIP
N/A
CIK
1136869
Web
www.zimmerbiomet.com
Phone
(574) 267-6131
Fax
574-372-4988
Employees
19,500
Year Founded
1927

Price Target and Rating

Average Stock Price Forecast
$124.05
High Stock Price Forecast
$155.00
Low Stock Price Forecast
$95.00
Forecasted Upside/Downside
-0.3%
Consensus Rating
Hold
Rating Score (0-4)
2.05
Research Coverage
21 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.32
Trailing P/E Ratio
94.24
Forward P/E Ratio
18.19
P/E Growth
2.37
Net Income
$401.60 million
Net Margins
3.89%
Pretax Margin
4.39%
Return on Equity
11.92%
Return on Assets
6.66%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.98
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$7.84 billion
Price / Sales
3.33
Cash Flow
$12.63 per share
Price / Cash Flow
9.85
Book Value
$60.63 per share
Price / Book
2.05

Miscellaneous

Outstanding Shares
209,852,000
Free Float
208,320,000
Market Cap
$26.11 billion
Optionable
Optionable
Beta
1.09

Social Links


Key Executives

  • Mr. Bryan C. HansonMr. Bryan C. Hanson (Age 55)
    Chairman, Pres & CEO
    Comp: $3.33M
  • Mr. Suketu P. Upadhyay (Age 53)
    Exec. VP & CFO
    Comp: $1.62M
  • Mr. Ivan Tornos (Age 46)
    Chief Operating Officer
    Comp: $1.68M
  • Mr. Sang YiMr. Sang Yi (Age 60)
    Group Pres of Asia Pacific
    Comp: $1.22M
  • Mr. Wilfred van Zuilen
    Pres of Europe, Middle East & Africa
  • Mr. Paul A. Stellato (Age 47)
    VP, Controller & Chief Accounting Officer
  • Dr. Nitin Goyal M.D.
    Chief Science, Technology & Innovation Officer
  • Mr. Zeeshan Tariq
    Sr. VP & Chief Information Officer
  • Ms. Keri P. Mattox
    Chief Communications & Admin. Officer and Sr. VP of Investor Relations
  • Mr. Chad F. PhippsMr. Chad F. Phipps (Age 50)
    Sr. VP, Gen. Counsel & Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?

21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 3 sell ratings, 14 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.

What is Zimmer Biomet's stock price forecast for 2023?

21 brokers have issued 12 month price targets for Zimmer Biomet's stock. Their ZBH share price forecasts range from $95.00 to $155.00. On average, they predict the company's stock price to reach $124.05 in the next year. This suggests that the stock has a possible downside of 0.3%.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.

How have ZBH shares performed in 2022?

Zimmer Biomet's stock was trading at $127.04 on January 1st, 2022. Since then, ZBH stock has decreased by 2.1% and is now trading at $124.40.
View the best growth stocks for 2022 here.

When is Zimmer Biomet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our ZBH earnings forecast.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) posted its earnings results on Wednesday, November, 2nd. The medical equipment provider reported $1.58 EPS for the quarter, beating the consensus estimate of $1.56 by $0.02. The medical equipment provider earned $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Zimmer Biomet had a trailing twelve-month return on equity of 11.92% and a net margin of 3.89%. The company's revenue for the quarter was down 13.2% on a year-over-year basis. During the same period last year, the company posted $1.81 EPS.
Read the conference call transcript.

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Friday, August 26th. Shareholders of record on Friday, September 30th will be paid a dividend of $0.24 per share on Monday, October 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Thursday, September 29th.
Read our dividend analysis for ZBH.

Is Zimmer Biomet a good dividend stock?

Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.76%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 72.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZBH will have a dividend payout ratio of 13.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $6.80-$6.90 for the period, compared to the consensus EPS estimate of $6.79. The company issued revenue guidance of $7.84 billion-$7.91 billion, compared to the consensus revenue estimate of $6.86 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?

240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.35%), BlackRock Inc. (10.24%), Price T Rowe Associates Inc. MD (5.03%), State Street Corp (4.11%), Primecap Management Co. CA (2.34%) and Boston Partners (1.26%). Insiders that own company stock include Arthur J Higgins, Bryan C Hanson, Chad F Phipps, Sang Yi and Zuilen Wilfred Van.
View institutional ownership trends.

How do I buy shares of Zimmer Biomet?

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $124.40.

How much money does Zimmer Biomet make?

Zimmer Biomet (NYSE:ZBH) has a market capitalization of $26.11 billion and generates $7.84 billion in revenue each year. The medical equipment provider earns $401.60 million in net income (profit) each year or $1.32 on an earnings per share basis.

How many employees does Zimmer Biomet have?

The company employs 19,500 workers across the globe.

Does Zimmer Biomet have any subsidiaries?
The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More
How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 12/9/2022 by MarketBeat.com Staff